Bourneville Syndrome - 17 Studies Found

Recruiting : A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
: Tuberous Sclerosis
: 2013-09-05
:
  • Drug: Placebo 5mg daily admini
Active, not recruiting : Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
: Tuberous Sclerosis Complex
: 2013-01-28
Completed : Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
: Tuberous Sclerosis Complex
: 2011-02-02
: Drug: RAD001 RAD001 is formulated as tablets of 5.0 mg str
Recruiting : Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
: Tuberous Sclerosis Complex
: 2016-02-10
: Behavioral: JASPER JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment ap
Recruiting : Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
: Tuberous Sclerosis Complex
: 2016-07-13
:
  • Drug: Vigabatrin Subjects rand
Completed : Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
:
  • Tuberous Sclerosis
  • Subependymal Giant Cell Astrocytoma
    • : 2006-12-12
    : Drug: Everolimus Initial everolimus dosage will be 3 mg/m2/d taken daily or every other day, with titrat
Active, not recruiting : A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
: Tuberous Sclerosis Complex-associated Refractory Seizures
: 2012-10-09
:
  • Drug: RAD001 Other Name: Afini
Active, not recruiting : Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
:
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis

: 2007-06-21
: Drug: sirolimus daily oral sirolimus with dosage individualised by trough blood levels
Completed : Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
:
  • Epilepsy
  • Tuberous Sclerosis Complex

: 2010-02-15
: Drug: Everolimus Everolimus is available in tablet form. The starting dose will be 5 mg/m2/day, rounded
Completed : Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
:
  • Tuberous Sclerosis
  • Subependymal Giant Cell Astrocytoma
    • : 2008-11-12
    :
    • Drug: Everolimus Everolimus wa
Next >>>